Credits: Canva
Quademic 2025: Hospitals in the United States are dealing with a surge in patients admission, the reason is the quademic it is dealing with at this moment. This has led to an influx of patients. It is all caused by seasonal infections, including common flu, Covid-19, and respiratory syncytial virus (RSV) that dominate the winter season in the US. This year, norovirus also joined the list, which has further increased the load on the healthcare.
The healthcare company founded in academics M Health Fairview, confirmed that their hospitals are overflowing due to the quademic.
The hospitals of M Health Fairview's volume is up by 30% and as a results, patients are being treated in the hallways and in alternative care areas. There is also a longer wait time and shortages for resources that are required to treat these emergencies. This has also impacted other life-threatening emergencies like heart attacks and strokes, as the healthcare resources and caregivers are occupied with the surge in seasonal cases.
ALSO READ: Birmingham Struggles With 4 Different Virus Hits, Know What They Are
Common cold and flu: The common cold and influenza (flu) are perhaps the most well-known illnesses that peak during the fall. As temperatures drop and humidity levels fluctuate, viruses that cause colds and the flu become more active. The flu, in particular, can be more severe than a common cold, leading to complications such as pneumonia, especially in vulnerable populations like the elderly and those with pre-existing health conditions. Symptoms include a runny nose, sore throat, coughing, fever, and body aches.
Covid-19: As per the World Health Organization, Coronavirus disease or COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with this virus will experience mild to moderate respiratory illness and recover without requiring special treatment, However, there could be some cases of seriously ill patients who may require medical attention. It is also because of the other existing medical conditions like cardiovascular diseases, diabetes, chronic respiratory diseases, cancers, or older age.
The best way to protect against this virus is by following social isolation form those who are infected, using mask to prevent droplets from infecting others when you cough or sneeze and to wash your hands for 20 seconds frequently.
RSV or Respiratory Syncytial Virus: As per the Centers of Diseases Control and Prevention (CDC), RSV is a common respiratory virus that infects nose, throat and lungs. Though symptoms are similar to the viruses like flu or COVID-19, the disease in itself is different. It also peaks during the winter season, especially between December and January.
However, the main difference between RSV and other respiratory illness, above mentioned is that RSV can cause pneumonia or bronchiolitis, especially for those who are over the age of 50 or with an existing heart or lung disease.
Norovirus: It is a number 1 cause of foodborne illness in the US and this happens when virus gets into the food and then it accidentally enters your mouth. These particles are from faeces or vomit from infected people, or can be transmitted via contaminated food and water. It could also spread by touching unclean surfaces like door handles or cutlery.
For most people, having norovirus is unpleasant, but mild and recovery could be made in 1 to 2 days. However, it could be more serious for babies, older people and anyone with any existing health condition.
Credit: AI
Sleep disorders have long been associated with daytime fatigue, poor concentration, and memory problems. Now, a new neuroimaging study suggests that the impact of sleep disorders could be deeper.
Researchers have found that people with sleep disorders show structural changes in brain regions involved in attention, motivation, decision-making, and emotional regulation.
The findings, published in the Nature Portfolio journal Scientific Reports, are based on one of the largest neuroimaging meta-analyses examining structural changes in the brain across multiple sleep disorders.
Researchers analyzed data from numerous brain imaging studies involving people diagnosed with various sleep disorders. The following alterations were absorbed in different regions of the brain:
“As more people recognize how important sleep is, there’s growing urgency to understand what’s happening in the brain,” said Matthew Sutherland, a cognitive neuroscientist at FIU and senior author of the study. “By bringing together results from many studies, this research gives us a clearer picture of how sleep disorders affect brain structure and function and where we need to focus next.”
According to the researchers, disrupted sleep may interfere with the brain's ability to maintain biological functions.
Rather than affecting a single region, sleep disorders appear to impact multiple interconnected networks in the brain.
“Most research looks at sleep disorders one at a time,” said Katharine Crooks, a recent FIU cognitive neuroscience doctoral graduate and lead author of the study. “By looking across many studies, we found shared patterns in the brain that help explain why sleep problems can impact focus, decision-making and everyday functioning. With so many people struggling with sleep, understanding what is happening in the brain is key to finding better interventions, diagnostic tools and personalized treatments.”
This could be why many people with chronic sleep disorders experience symptoms beyond tiredness. Some of them are:
Also read: Pediatric Sleep: The Foundation Of Healthy Growth, Behavior And Society
These symptoms are commonly reported in conditions like insomnia, obstructive sleep apnea, restless legs syndrome, and other chronic sleep disorders.
The new study adds to the evidence that healthy sleep is essential for maintaining optimum cognitive function.
Previous studies have linked sleep deprivation to poor attention, slower reflexes, increased dementia risk, and poor emotional processing.
They have also indicated that even chronic sleep deprivation can contribute to changes in brain health alongside metabolic and cardiovascular effects.
Also read: Why Are Sleep Disorder Cases Rising In Children Under 10 In South Korea?
In an earlier study, researchers discovered that even just three nights of insufficient sleep were enough to change blood chemistry, affecting heart health.
In the study, it was observed that the levels of proteins linked to a higher risk of heart disease and inflammation went up after just three nights of poor sleep.
It was further observed that while exercise had some positive effects on protein levels, it wasn't enough to completely eliminate the harm caused by not sleeping enough. Even with exercise, participants still showed increased levels of 16 proteins associated with heart disease.
The study points out how young and healthy people can face these negative biological changes from short-term sleep loss.
Persistent problems with falling asleep, staying asleep, excessive daytime sleepiness, or interrupted breathing during sleep deserve immediate medical attention.
As researchers continue to unravel how sleep shapes the brain, one message has become increasingly clear: quality sleep is not simply a time of rest. It is an essential biological process that supports physical health, attention span, decision-making, emotional well-being, and overall cognitive health.
Credit: AI
Tiny plastic particles in the human body may cause serious heart attacks. A recent study observed that people who had microplastics present in their arteries supplying blood to the heart are more likely to experience severe heart attacks.
The study has raised concerns about the effects of plastic pollution on cardiovascular health.
A new study published in the European Heart Journal has found that people with microplastics present in the arteries supplying blood to the heart were more likely to experience larger and more severe heart attacks, raising concerns about the cardiovascular effects of plastic pollution.
Microplastics are plastic fragments smaller than five millimeters that originate from the breakdown of larger plastic items.
“Micro and nanoplastics are tiny plastic particles that are found virtually everywhere in the environment, including the air we breathe, the water we drink, and many foods we consume,” said Pasquale Paolisso, lead author of the study.
Although microplastics have already been detected in human blood, lungs, brain, and arteries, researchers are still trying to understand their long-term health effects.
Also read: Recovering From A Heart Attack? Avoid These Dangerous Mistakes
In the latest study, researchers analyzed 61 Italian patients who were treated for heart attacks and measured the presence of microplastics in blood collected from the coronary arteries.
Researchers also collected data on whether the patients were smokers and on their exposure to pollution.
“In our study, smoking history was strongly linked to microplastics in the blood. Our findings suggest that smoking might make it easier for micro and nanoplastics to enter the bloodstream via the lungs. Air pollution may act in a similar way,” Dr Emanuele Barbato, an author of the study from Sapienza University of Rome, said.
Scientists detected micro and nanoplastics in 84 per cent of patients who had heart attacks.
In comparison, only 40 per cent of patients with chronic ischemic heart disease and 32 per cent of patients with normal coronary arteries were found to have micro and nanoplastics.
They discovered that patients with higher levels of microplastics tended to have larger areas of heart muscle damage and greater inflammation, suggesting that these particles may be linked to more severe cardiovascular events.
“While the findings do not prove that plastics directly cause heart attacks, they strengthen the growing scientific evidence that plastic pollution is an emerging public health issue deserving serious attention,” said Thava Palanisami,” a plastic researcher at the University of Newcastle in Australia.
The study is built on earlier research published in 2024, which found that patients whose arterial plaque contained microplastics and nanoplastics were more than four times as likely to suffer a heart attack, stroke, or death.
That landmark study was among the first to find that plastics accumulating inside blood vessels could have important clinical consequences.
Scientists believe microplastics may trigger chronic inflammation and oxidative stress, damage the cells lining blood vessels, and make fatty plaques in arteries more unstable. This could increase the likelihood of heart attacks.
Credit: AP
Almost a year after the last Senate-confirmed director of the US Centers for Disease Control and Prevention (CDC), was fired for backing science and vaccines, President Donald Trump has nominated Dr. Erica Schwartz to head the agency, making her his third CDC nominee in less than two years.
Appearing before the Senate Committee on Health, Education, Labor, and Pensions (HELP) for her confirmation hearing on Wednesday, Schwartz pledged to restore public trust in the CDC through transparency and evidence-based decision-making.
However, she also faced pointed questions about vaccine policy, scientific independence, and whether she would resist pressure from Health Secretary Robert F. Kennedy Jr.
Schwartz highlighted her military background and said restoring confidence in public health institutions would be her top priority.
"If confirmed, my first priority will be restoring trust in public health institutions through radical transparency and unwavering scientific integrity," she said.
"As CDC director, my sacred responsibility is to provide the American people with public health guidance that is clear, honest, and evidence-based. I will never betray science," she added.
Schwartz previously served as deputy US surgeon general during Trump's first administration and held the rank of rear admiral in the US Coast Guard.
Dr. Erica Schwartz is a physician with an extensive background in medicine, public health, engineering, and law. She holds a medical degree (MD), a Master of Public Health (MPH) in epidemiology, a law degree, and a degree in biomedical engineering.
Before being nominated to lead the CDC, Schwartz held several senior public health and military leadership roles, including:
Throughout the hearing, Schwartz repeatedly expressed support for vaccines, including mRNA COVID-19 vaccines, and strongly endorsed vitamin K injections for newborns to prevent life-threatening bleeding.
She also acknowledged that scientific evidence does not support a link between vaccines and autism, while arguing that more research is needed to better understand the rising prevalence of autism.
"We owe it to the American people to figure out why one in 30 children now has autism," she said.
Schwartz stated that she did not believe either President Trump or Health Secretary Kennedy would ask her to take actions that would harm public health or violate the law.
She also said she was unaware of Kennedy's decision to cancel nearly $500 million in mRNA vaccine contracts and was unfamiliar with reported cuts to smoking cessation and food safety programmes.
Although many observers consider Schwartz a qualified nominee with mainstream public health credentials, some experts said her testimony did not provide enough reassurance that she would independently defend scientific evidence if political pressure arose.
Dr. Jeanne Marrazzo, chief executive of the Infectious Diseases Society of America, said she wanted stronger commitments to evidence-based science from leaders overseeing the nation's top public health institutions.
The hearing also renewed criticism of Health Secretary Robert F. Kennedy Jr.'s handling of the CDC.
Several Democratic senators, including Sen. Bernie Sanders, argued that former CDC director Dr. Susan Monarez was removed because she resisted Kennedy's vaccine policies.
"Dr. Monarez, to her credit, stood up for science, public health, and for the scientific method. Frankly, she stood up for protecting the well-being of the American people, and that was the reason that she was fired," Sanders said.
If confirmed by the Senate, Schwartz would replace Dr. Jay Bhattacharya, who’s been serving as acting CDC director since February.
© 2024 Bennett, Coleman & Company Limited